Intelligence / Healthtech / New Clinical Trials / Desentum Oy
Clinicaltrial registered27 Oct 2026
Desentum Oy
27 Oct 2026: Trial registered · Safety, Tolerability And Pharmacodynamics of DM-101PX in Birch Pollen Allergy. Recorded in the ClinicalTrials.gov (US National Library of Medicine).
- Posted
- 27 Oct 2026
- Title
- Safety, Tolerability And Pharmacodynamics of DM-101PX in Birch Pollen Allergy
- Conditions
- Birch Pollen Allergy
- Phase
- Phase 1
- Study Type
- Interventional
- Status
- Recruiting
- Countries
- Germany
- Country
- Germany
- Reference
- NCT07898800
- Location
- Germany
What this signal means
A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at Desentum Oy
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.
More from Germany
New Clinical Trials
18 NovDiabetes Free, Inc.trial registered · Dual-targeting of B & T Cell Pathways Evaluation TrialClinical18 NovGaia AGtrial registered · Investigating the Effectiveness of Calisda, a Digital Health Intervention for Patients With Menopause SymptomsClinical16 NovBoehringer Ingelheimtrial registered · A Study to Compare How Survodutide is Taken up by the Body When Given in 2 Formulations to People With Overweight or ObesityClinical16 NovFinzelberg GmbH & Co. KGtrial registered · Effects of a Botanical Extract on Cognitive Performance and Cerebral Blood Flow in Healthy AdultsClinical13 NovCutempa Medical AGtrial registered · Silica-Based Wound Treatment (Curi01) Plus Standard Care Versus Standard Care Alone for Chronic Diabetic Foot WoundsClinical12 NovAponia Laboratories, Inc.trial registered · Effect of S-Ibuprofen Gel on Pain in Acute Soft Tissue ContusionsClinical
Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.